CompletedPhase 4

Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?

Denmark413 participantsStarted 2004-10

Plain-language summary

How to use drug eluting stents (DES) in bifurcation lesions. A strategy of routine stenting of both main vessel and side branch versus a strategy of routine main vessel stenting and optional treatment of side branch. A randomized Nordic multicenter study including 400 patients with angina pectoris with clinical angiographic follow-up.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Stable or unstable AP. * Bifurcation lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA-PDA/posterolateral branch or LM/Cx/LAD in a right dominant system. * Diameter of main vessel by visual estimate \> 2.5 mm. * Diameter of side branch by visual estimate \> 2.0 mm. * Signed informed consent. Exclusion Criteria: * ST-elevation AMI within 24 hours. * Expected survival \< 1 year. * S-creatinine \> 200 Umol/l. * Allergy to Aspirin, Clopidogrel or Ticlopidine. * Allergy to sirolimus/paclitaxel. * Left main bifurcation in a non-right dominant system.

What they're measuring

Combined end-point of cardiac death, MI, stent thrombosis or TVR.

Timeframe: After 6 months

Trial details

NCT IDNCT00376571

SponsorAarhus University Hospital Skejby

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2005-06

View on ClinicalTrials.gov More Coronary Artery Disease trials